10 Hot Biotech Stocks Under $5 to Buy
On June 4, 2026, CNBC reported that global biopharma M&A is on track for its strongest year since the pre-pandemic peak seven years ago.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Persistent Asset Partners Xin Huang | 3,707 | $8,304 | 0% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 331,014 | $741,471 | 0.79% | |
| 2. | 155,416 | $348,132 | 0% | |
| 3. | 95,000 | $212,800 | 0% | |
| 4. | 18,154 | $40,665 | 0% | |
| 5. | 16,000 | $35,840 | 0% |